Unity Biotechnology, Inc.
UBX
$0.977
-$0.0067-0.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 2.77M | 12.51M | 56.00K | 117.00K | 3.72M |
| Gross Profit | -2.77M | -12.51M | -56.00K | -117.00K | -3.72M |
| SG&A Expenses | 4.12M | 4.25M | 3.82M | 3.52M | 3.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.89M | 7.29M | 6.60M | 6.98M | 7.60M |
| Operating Income | -6.89M | -7.29M | -6.60M | -6.98M | -7.60M |
| Income Before Tax | -7.30M | -8.44M | -6.48M | -5.28M | -5.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.30M | -8.44M | -6.48M | -5.28M | -5.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.30M | -8.44M | -6.48M | -5.28M | -5.79M |
| EBIT | -6.89M | -7.29M | -6.60M | -6.98M | -7.60M |
| EBITDA | -6.71M | -7.08M | -6.39M | -6.76M | -7.37M |
| EPS Basic | -0.43 | -0.50 | -0.38 | -0.31 | -0.34 |
| Normalized Basic EPS | -0.27 | -0.21 | -0.24 | -0.20 | -0.22 |
| EPS Diluted | -0.43 | -0.50 | -0.38 | -0.31 | -0.34 |
| Normalized Diluted EPS | -0.27 | -0.21 | -0.24 | -0.20 | -0.22 |
| Average Basic Shares Outstanding | 16.87M | 16.86M | 16.85M | 16.82M | 16.79M |
| Average Diluted Shares Outstanding | 16.87M | 16.86M | 16.85M | 16.82M | 16.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |